Oncogene, ISSN 0950-9232, 08/2013, Volume 32, Issue 32, pp. 3765 - 3781
Identification of regulatable mechanisms by which transcription factor NF-E2 p45-related factor 2 (Nrf2) is repressed will allow strategies to be designed that...
b-TrCP | GSK-3 | drug resistance | Nrf2 | ubiquitylation | oxidative stress | PROTEASOMAL DEGRADATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | GLYCOGEN-SYNTHASE KINASE-3 | MAP KINASES | beta-TrCP | CELL BIOLOGY | E3 LIGASE | TRANSCRIPTION FACTOR NRF2 | ANTIOXIDANT RESPONSE ELEMENT | ONCOLOGY | NEGATIVE REGULATION | GENETICS & HEREDITY | HEME OXYGENASE-1 | KEAP1 GENE | NF-E2-Related Factor 2 - physiology | Protein Structure, Tertiary | Phosphorylation | p38 Mitogen-Activated Protein Kinases - physiology | Humans | Glycogen Synthase Kinase 3 - metabolism | beta-Transducin Repeat-Containing Proteins - chemistry | NF-E2-Related Factor 2 - analysis | Ubiquitination | beta-Transducin Repeat-Containing Proteins - metabolism | Animals | Phosphatidylinositol 3-Kinases - physiology | Antineoplastic Agents - pharmacology | Mice | NF-E2-Related Factor 2 - chemistry | Extracellular Signal-Regulated MAP Kinases - physiology | Intracellular Signaling Peptides and Proteins - physiology | Binding Sites | Kelch-Like ECH-Associated Protein 1 | β-TrCP
b-TrCP | GSK-3 | drug resistance | Nrf2 | ubiquitylation | oxidative stress | PROTEASOMAL DEGRADATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | GLYCOGEN-SYNTHASE KINASE-3 | MAP KINASES | beta-TrCP | CELL BIOLOGY | E3 LIGASE | TRANSCRIPTION FACTOR NRF2 | ANTIOXIDANT RESPONSE ELEMENT | ONCOLOGY | NEGATIVE REGULATION | GENETICS & HEREDITY | HEME OXYGENASE-1 | KEAP1 GENE | NF-E2-Related Factor 2 - physiology | Protein Structure, Tertiary | Phosphorylation | p38 Mitogen-Activated Protein Kinases - physiology | Humans | Glycogen Synthase Kinase 3 - metabolism | beta-Transducin Repeat-Containing Proteins - chemistry | NF-E2-Related Factor 2 - analysis | Ubiquitination | beta-Transducin Repeat-Containing Proteins - metabolism | Animals | Phosphatidylinositol 3-Kinases - physiology | Antineoplastic Agents - pharmacology | Mice | NF-E2-Related Factor 2 - chemistry | Extracellular Signal-Regulated MAP Kinases - physiology | Intracellular Signaling Peptides and Proteins - physiology | Binding Sites | Kelch-Like ECH-Associated Protein 1 | β-TrCP
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 09/2008, Volume 178, Issue 6, pp. 592 - 604
Rationale Oxidative stress is a key contributor in chronic obstructive pulmonary disease (COPD) pathogenesis caused by cigarette smoking. NRF2, a...
Antioxidants | Oxidative stress | Chronic obstructive pulmonary disease | DJ-1 | NRF2 | NRF2 ENHANCES SUSCEPTIBILITY | OXIDATIVE DAMAGE | antioxidants | INDUCED INFLAMMATORY RESPONSE | AIRWAY INFLAMMATION | HEME OXYGENASE-1 GENE | CHEMOPREVENTIVE AGENT SULFORAPHANE | GAMMA-GLUTAMYLCYSTEINE SYNTHETASE | TRANSCRIPTION FACTOR NRF2 | EPITHELIAL-CELLS | RESPIRATORY SYSTEM | CIGARETTE-SMOKE | oxidative stress | chronic obstructive pulmonary disease | CRITICAL CARE MEDICINE | NF-E2-Related Factor 2 - physiology | Glutathione - metabolism | Humans | Middle Aged | Oxidative Stress - physiology | Lung - chemistry | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Oncogene Proteins - physiology | Smoking - physiopathology | Female | Thiobarbituric Acid Reactive Substances - analysis | Pulmonary Disease, Chronic Obstructive - metabolism | Antioxidants - analysis | Cells, Cultured | Epithelial Cells | Mice, Inbred Strains | Protein Deglycase DJ-1 | Smoking - metabolism | NF-E2-Related Factor 2 - analysis | Animals | Signal Transduction - physiology | Mice | NAD(P)H Dehydrogenase (Quinone) - analysis | Oxidative Stress - drug effects | Intracellular Signaling Peptides and Proteins - physiology | Lipid Peroxidation | B. Chronic Obstructive Pulmonary Disease
Antioxidants | Oxidative stress | Chronic obstructive pulmonary disease | DJ-1 | NRF2 | NRF2 ENHANCES SUSCEPTIBILITY | OXIDATIVE DAMAGE | antioxidants | INDUCED INFLAMMATORY RESPONSE | AIRWAY INFLAMMATION | HEME OXYGENASE-1 GENE | CHEMOPREVENTIVE AGENT SULFORAPHANE | GAMMA-GLUTAMYLCYSTEINE SYNTHETASE | TRANSCRIPTION FACTOR NRF2 | EPITHELIAL-CELLS | RESPIRATORY SYSTEM | CIGARETTE-SMOKE | oxidative stress | chronic obstructive pulmonary disease | CRITICAL CARE MEDICINE | NF-E2-Related Factor 2 - physiology | Glutathione - metabolism | Humans | Middle Aged | Oxidative Stress - physiology | Lung - chemistry | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Oncogene Proteins - physiology | Smoking - physiopathology | Female | Thiobarbituric Acid Reactive Substances - analysis | Pulmonary Disease, Chronic Obstructive - metabolism | Antioxidants - analysis | Cells, Cultured | Epithelial Cells | Mice, Inbred Strains | Protein Deglycase DJ-1 | Smoking - metabolism | NF-E2-Related Factor 2 - analysis | Animals | Signal Transduction - physiology | Mice | NAD(P)H Dehydrogenase (Quinone) - analysis | Oxidative Stress - drug effects | Intracellular Signaling Peptides and Proteins - physiology | Lipid Peroxidation | B. Chronic Obstructive Pulmonary Disease
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 03/2015, Volume 290, Issue 11, pp. 6731 - 6750
Non-thermal atmospheric pressure plasma provides a novel therapeutic opportunity to control redox-based processes, e.g. wound healing, cancer, and inflammatory...
OXIDATIVE STRESS | IN-VITRO | REDOX REGULATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | NUCLEAR EXPORT | HACAT KERATINOCYTES | HEME OXYGENASE-1 | C-JUN | GROWTH-FACTOR SYNTHESIS | TRANSCRIPTIONAL REPRESSOR | ATMOSPHERIC-PRESSURE PLASMA | Cell Line | Cell Survival - drug effects | RNA, Small Interfering - genetics | Heme Oxygenase-1 - metabolism | Reactive Oxygen Species - metabolism | Glutathione - metabolism | Reactive Nitrogen Species - metabolism | Antioxidants - metabolism | Humans | Keratinocytes - cytology | Transcriptome - drug effects | Plasma Gases - pharmacology | Heme Oxygenase-1 - genetics | NF-E2-Related Factor 2 - analysis | Keratinocytes - drug effects | Signal Transduction - drug effects | Keratinocytes - metabolism | NF-E2-Related Factor 2 - metabolism | Oxidation-Reduction - drug effects | NF-E2-Related Factor 2 - genetics | Oxidative Stress - drug effects | Keratinocyte | Gene Expression | Reactive Oxygen Species (ROS) | Oxidative Stress | Reactive Nitrogen Species (RNS) | Cell Biology
OXIDATIVE STRESS | IN-VITRO | REDOX REGULATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | NUCLEAR EXPORT | HACAT KERATINOCYTES | HEME OXYGENASE-1 | C-JUN | GROWTH-FACTOR SYNTHESIS | TRANSCRIPTIONAL REPRESSOR | ATMOSPHERIC-PRESSURE PLASMA | Cell Line | Cell Survival - drug effects | RNA, Small Interfering - genetics | Heme Oxygenase-1 - metabolism | Reactive Oxygen Species - metabolism | Glutathione - metabolism | Reactive Nitrogen Species - metabolism | Antioxidants - metabolism | Humans | Keratinocytes - cytology | Transcriptome - drug effects | Plasma Gases - pharmacology | Heme Oxygenase-1 - genetics | NF-E2-Related Factor 2 - analysis | Keratinocytes - drug effects | Signal Transduction - drug effects | Keratinocytes - metabolism | NF-E2-Related Factor 2 - metabolism | Oxidation-Reduction - drug effects | NF-E2-Related Factor 2 - genetics | Oxidative Stress - drug effects | Keratinocyte | Gene Expression | Reactive Oxygen Species (ROS) | Oxidative Stress | Reactive Nitrogen Species (RNS) | Cell Biology
Journal Article
Journal of Clinical Pathology, ISSN 0021-9746, 04/2019, Volume 72, Issue 4, pp. 316 - 321
AimsOxidative stress markers and antioxidant enzymes have previously been shown to have prognostic value and associate with adverse outcome in patients with...
nrf2 | diffuse large B-cell lymphoma | keap1 | nrf1 | bach1 | KEAP1 | OXIDATIVE STRESS | ACTIVATION | PATHOLOGY | NRF2 INHIBITOR | EXPRESSION | Immunohistochemistry | Antineoplastic Agents, Immunological - administration & dosage | Predictive Value of Tests | Prednisolone - adverse effects | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cytoplasm - pathology | Young Adult | Cell Nucleus - pathology | Lymphoma, Large B-Cell, Diffuse - chemistry | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Rituximab - adverse effects | Cytoplasm - chemistry | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | NF-E2-Related Factor 1 - analysis | Risk Assessment | Biomarkers, Tumor - analysis | Risk Factors | Etoposide - administration & dosage | Treatment Outcome | Kelch-Like ECH-Associated Protein 1 - analysis | Lymphoma, Large B-Cell, Diffuse - mortality | Rituximab - administration & dosage | Antineoplastic Agents, Immunological - adverse effects | Basic-Leucine Zipper Transcription Factors - analysis | NF-E2-Related Factor 2 - analysis | Vincristine - adverse effects | Aged | Cell Nucleus - chemistry | Neoplasm Staging | Doxorubicin - adverse effects | Medical research | Enzymes | Oxidative stress | Transcription factors | Disease | Lung cancer | Colorectal cancer | Nervous system | Metastasis | Gene expression | Patients | Cancer therapies | Antioxidants | Proteins | Survival analysis | Hospitals | Medical prognosis | Epigenetics | Lymphomas | Original | 1506
nrf2 | diffuse large B-cell lymphoma | keap1 | nrf1 | bach1 | KEAP1 | OXIDATIVE STRESS | ACTIVATION | PATHOLOGY | NRF2 INHIBITOR | EXPRESSION | Immunohistochemistry | Antineoplastic Agents, Immunological - administration & dosage | Predictive Value of Tests | Prednisolone - adverse effects | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cytoplasm - pathology | Young Adult | Cell Nucleus - pathology | Lymphoma, Large B-Cell, Diffuse - chemistry | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Rituximab - adverse effects | Cytoplasm - chemistry | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | NF-E2-Related Factor 1 - analysis | Risk Assessment | Biomarkers, Tumor - analysis | Risk Factors | Etoposide - administration & dosage | Treatment Outcome | Kelch-Like ECH-Associated Protein 1 - analysis | Lymphoma, Large B-Cell, Diffuse - mortality | Rituximab - administration & dosage | Antineoplastic Agents, Immunological - adverse effects | Basic-Leucine Zipper Transcription Factors - analysis | NF-E2-Related Factor 2 - analysis | Vincristine - adverse effects | Aged | Cell Nucleus - chemistry | Neoplasm Staging | Doxorubicin - adverse effects | Medical research | Enzymes | Oxidative stress | Transcription factors | Disease | Lung cancer | Colorectal cancer | Nervous system | Metastasis | Gene expression | Patients | Cancer therapies | Antioxidants | Proteins | Survival analysis | Hospitals | Medical prognosis | Epigenetics | Lymphomas | Original | 1506
Journal Article
Cancer Cell, ISSN 1535-6108, 12/2013, Volume 24, Issue 6, pp. 738 - 750
Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer and is often linked to loss of chromosome 3p, which harbors the tumor...
BETA-DOMAIN | TRANSCRIPTION FACTOR NRF2 | LINDAU GENE-PRODUCT | ONCOLOGY | TUMOR-SUPPRESSOR PROTEIN | AUTOPHAGY | IDENTIFICATION | P62 | TUMORIGENESIS | RENAL-CELL CARCINOMA | P62/SEQUESTOSOME 1 | CELL BIOLOGY | NF-E2-Related Factor 2 - physiology | Kidney Neoplasms - genetics | Sequestosome-1 Protein | Humans | Carcinoma, Renal Cell - genetics | Molecular Sequence Data | Gene Dosage | Chromosomes, Human, Pair 5 | Adaptor Proteins, Signal Transducing - physiology | NF-E2-Related Factor 2 - analysis | Animals | Base Sequence | Adaptor Proteins, Signal Transducing - genetics | Cell Line, Tumor | Mice | Medical colleges | Genes | Kidney cancer | Cancer
BETA-DOMAIN | TRANSCRIPTION FACTOR NRF2 | LINDAU GENE-PRODUCT | ONCOLOGY | TUMOR-SUPPRESSOR PROTEIN | AUTOPHAGY | IDENTIFICATION | P62 | TUMORIGENESIS | RENAL-CELL CARCINOMA | P62/SEQUESTOSOME 1 | CELL BIOLOGY | NF-E2-Related Factor 2 - physiology | Kidney Neoplasms - genetics | Sequestosome-1 Protein | Humans | Carcinoma, Renal Cell - genetics | Molecular Sequence Data | Gene Dosage | Chromosomes, Human, Pair 5 | Adaptor Proteins, Signal Transducing - physiology | NF-E2-Related Factor 2 - analysis | Animals | Base Sequence | Adaptor Proteins, Signal Transducing - genetics | Cell Line, Tumor | Mice | Medical colleges | Genes | Kidney cancer | Cancer
Journal Article
Journal of Endodontics, ISSN 0099-2399, 2014, Volume 40, Issue 8, pp. 1194 - 1200
Abstract Introduction The objective of this study was to evaluate the biocompatibility, inflammatory response, and odontoblastic potential of Biodentine...
Endocrinology & Metabolism | Dentistry | Biodentine | nuclear factor–E2-related factor-2 | dental pulp cells | odontoblastic potential | inflammatory response | Biocompatibility | heme oxygenase-1 | nuclear factor-E2-related factor-2 | nuclear factor E2-related factor-2 | PROLIFERATION | TRIOXIDE AGGREGATE | HEAT-STRESS | ODONTOBLASTIC DIFFERENTIATION | MATRIX METALLOPROTEINASES | IN-VITRO | CLINICAL-APPLICATIONS | DENTISTRY, ORAL SURGERY & MEDICINE | GENE-EXPRESSION | END-FILLING MATERIALS | Dinoprostone - analysis | Cytokines - analysis | Humans | Dental Cements - pharmacology | Nitric Oxide - analysis | Nitric Oxide Synthase Type II - analysis | Inflammation Mediators - analysis | Mitogen-Activated Protein Kinases - analysis | Alkaline Phosphatase - analysis | Pulp Capping and Pulpectomy Agents - pharmacology | Calcium Compounds - pharmacology | Silicates - pharmacology | Calcification, Physiologic - drug effects | Dental Pulp - cytology | Dental Pulp - drug effects | Materials Testing | Biocompatible Materials - pharmacology | Zinc Oxide-Eugenol Cement - pharmacology | Cyclooxygenase 2 - analysis | Reactive Oxygen Species - analysis | Oxides - pharmacology | NF-E2-Related Factor 2 - analysis | Heme Oxygenase-1 - analysis | Signal Transduction - drug effects | Cell Differentiation - drug effects | Methylmethacrylates - pharmacology | Odontoblasts - drug effects | Bismuth - pharmacology | Root Canal Filling Materials - pharmacology | Aluminum Compounds - pharmacology | Cell Proliferation - drug effects | Drug Combinations
Endocrinology & Metabolism | Dentistry | Biodentine | nuclear factor–E2-related factor-2 | dental pulp cells | odontoblastic potential | inflammatory response | Biocompatibility | heme oxygenase-1 | nuclear factor-E2-related factor-2 | nuclear factor E2-related factor-2 | PROLIFERATION | TRIOXIDE AGGREGATE | HEAT-STRESS | ODONTOBLASTIC DIFFERENTIATION | MATRIX METALLOPROTEINASES | IN-VITRO | CLINICAL-APPLICATIONS | DENTISTRY, ORAL SURGERY & MEDICINE | GENE-EXPRESSION | END-FILLING MATERIALS | Dinoprostone - analysis | Cytokines - analysis | Humans | Dental Cements - pharmacology | Nitric Oxide - analysis | Nitric Oxide Synthase Type II - analysis | Inflammation Mediators - analysis | Mitogen-Activated Protein Kinases - analysis | Alkaline Phosphatase - analysis | Pulp Capping and Pulpectomy Agents - pharmacology | Calcium Compounds - pharmacology | Silicates - pharmacology | Calcification, Physiologic - drug effects | Dental Pulp - cytology | Dental Pulp - drug effects | Materials Testing | Biocompatible Materials - pharmacology | Zinc Oxide-Eugenol Cement - pharmacology | Cyclooxygenase 2 - analysis | Reactive Oxygen Species - analysis | Oxides - pharmacology | NF-E2-Related Factor 2 - analysis | Heme Oxygenase-1 - analysis | Signal Transduction - drug effects | Cell Differentiation - drug effects | Methylmethacrylates - pharmacology | Odontoblasts - drug effects | Bismuth - pharmacology | Root Canal Filling Materials - pharmacology | Aluminum Compounds - pharmacology | Cell Proliferation - drug effects | Drug Combinations
Journal Article
Cancer Letters, ISSN 0304-3835, 01/2018, Volume 412, pp. 37 - 45
Multiple myeloma (MM) is an incurable disease characterized by clonal plasma cell proliferation. The stress response transcription factor Nuclear factor...
Oxidative stress | NRF2 or nuclear factor erythroid 2 [NF-E2]-related factor 2 | Endoplasmic reticulum | Multiple myeloma | CELLS | ACTIVATION | REDOX HOMEOSTASIS | BORTEZOMIB | HUMAN MONOCYTES | UNFOLDED PROTEIN RESPONSE | ONCOLOGY | RESISTANCE | LEUKEMIA | PROTEASOME INHIBITORS | CYTOTOXICITY | NF-E2-Related Factor 2 - physiology | NF-E2-Related Factor 2 - antagonists & inhibitors | Proteasome Inhibitors - pharmacology | Glutathione - metabolism | Humans | Transcription Factor CHOP - analysis | Multiple Myeloma - metabolism | Multiple Myeloma - drug therapy | Multiple Myeloma - pathology | NF-E2-Related Factor 2 - analysis | Cell Line, Tumor | Apoptosis | Endoplasmic Reticulum Stress - physiology | Antioxidants | Medical colleges | Protein binding | Cell proliferation | Biotechnology | Reactive oxygen species | Physiological effects | Transcription factors | Homeostasis | Homology | CCAAT/enhancer-binding protein | Drug resistance | Cancer therapies | Proteins | Cell growth | Penicillin | Drug metabolism | Bone marrow | Inhibition | Stresses | Cell survival | Manufacturers | Metabolism | Gene expression | Survival | Proteasome inhibitors | Chemotherapy | Cell lines | Viability | Tumors
Oxidative stress | NRF2 or nuclear factor erythroid 2 [NF-E2]-related factor 2 | Endoplasmic reticulum | Multiple myeloma | CELLS | ACTIVATION | REDOX HOMEOSTASIS | BORTEZOMIB | HUMAN MONOCYTES | UNFOLDED PROTEIN RESPONSE | ONCOLOGY | RESISTANCE | LEUKEMIA | PROTEASOME INHIBITORS | CYTOTOXICITY | NF-E2-Related Factor 2 - physiology | NF-E2-Related Factor 2 - antagonists & inhibitors | Proteasome Inhibitors - pharmacology | Glutathione - metabolism | Humans | Transcription Factor CHOP - analysis | Multiple Myeloma - metabolism | Multiple Myeloma - drug therapy | Multiple Myeloma - pathology | NF-E2-Related Factor 2 - analysis | Cell Line, Tumor | Apoptosis | Endoplasmic Reticulum Stress - physiology | Antioxidants | Medical colleges | Protein binding | Cell proliferation | Biotechnology | Reactive oxygen species | Physiological effects | Transcription factors | Homeostasis | Homology | CCAAT/enhancer-binding protein | Drug resistance | Cancer therapies | Proteins | Cell growth | Penicillin | Drug metabolism | Bone marrow | Inhibition | Stresses | Cell survival | Manufacturers | Metabolism | Gene expression | Survival | Proteasome inhibitors | Chemotherapy | Cell lines | Viability | Tumors
Journal Article
Molecular Nutrition & Food Research, ISSN 1613-4125, 03/2018, Volume 62, Issue 5, pp. 1700647 - n/a
Scope Blueberry consumption is believed to confer a cardiovascular health advantage, but the active compounds and effects require characterization. This study...
bioavailability | nuclear factor erythroid 2‐related factor | vascular effects | blueberries | phenolic acids | nuclear factor erythroid 2-related factor | METABOLITES | ACTIVATION | FOOD SCIENCE & TECHNOLOGY | ANTHOCYANINS | BLOOD-PRESSURE | CONTROLLED CLINICAL-TRIAL | WILD BLUEBERRY | ARTERIAL STIFFNESS | DOUBLE-BLIND | (POLY)PHENOLS | HYDROGEN-PEROXIDE | NF-E2-Related Factor 2 - physiology | Cell Survival - drug effects | Hydroxybenzoates - pharmacology | NF-E2-Related Factor 2 - analysis | Heme Oxygenase-1 - analysis | Humans | Blueberry Plants - chemistry | Cells, Cultured | Fruit and Vegetable Juices - analysis | Heme Oxygenase-1 - physiology | Antioxidants - pharmacology | Endothelial Cells - drug effects | Antioxidants | Cysteine | Metabolites | Ligases | Heme | Physiological aspects | Glutamate | Gene expression | Endothelium | Translocation | Hydrogen peroxide | Bioavailability | Phenolic acids | Biological activity | Nuclear transport | Endothelial cells | Proteins | Oxygenase | Acids | Phenols | Pretreatment | Human behavior | Blueberries
bioavailability | nuclear factor erythroid 2‐related factor | vascular effects | blueberries | phenolic acids | nuclear factor erythroid 2-related factor | METABOLITES | ACTIVATION | FOOD SCIENCE & TECHNOLOGY | ANTHOCYANINS | BLOOD-PRESSURE | CONTROLLED CLINICAL-TRIAL | WILD BLUEBERRY | ARTERIAL STIFFNESS | DOUBLE-BLIND | (POLY)PHENOLS | HYDROGEN-PEROXIDE | NF-E2-Related Factor 2 - physiology | Cell Survival - drug effects | Hydroxybenzoates - pharmacology | NF-E2-Related Factor 2 - analysis | Heme Oxygenase-1 - analysis | Humans | Blueberry Plants - chemistry | Cells, Cultured | Fruit and Vegetable Juices - analysis | Heme Oxygenase-1 - physiology | Antioxidants - pharmacology | Endothelial Cells - drug effects | Antioxidants | Cysteine | Metabolites | Ligases | Heme | Physiological aspects | Glutamate | Gene expression | Endothelium | Translocation | Hydrogen peroxide | Bioavailability | Phenolic acids | Biological activity | Nuclear transport | Endothelial cells | Proteins | Oxygenase | Acids | Phenols | Pretreatment | Human behavior | Blueberries
Journal Article
Cellular Physiology and Biochemistry, ISSN 1015-8987, 06/2017, Volume 41, Issue 6, pp. 2255 - 2267
Background: Allicin, a major component of garlic, is regarded as a cardioprotective agent and is associated with increased endothelial function. Methods: The...
HUVEC | Inflammation | Allicin | Mitochondrial dysfunction | Nrf2 | Atherosclerosis | CANCER-CELLS | APOPTOSIS | PHYSIOLOGY | RISK-FACTORS | FENOFIBRATE | BLOOD-PRESSURE | GARLIC POWDER | HIGH GLUCOSE | THERAPEUTIC TARGETS | GENERATION | Human Umbilical Vein Endothelial Cells | Inflammation - pathology | Neutrophils - cytology | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Liver X Receptors - antagonists & inhibitors | Humans | Sulfinic Acids - pharmacology | Membrane Potential, Mitochondrial - drug effects | RNA Interference | Lipid Peroxidation - drug effects | Neutrophils - metabolism | Malondialdehyde - metabolism | Lipopolysaccharides - toxicity | Cytochromes c - metabolism | Liver X Receptors - metabolism | Mitochondria - metabolism | Mitochondria - drug effects | Cell Adhesion - drug effects | Interleukin-8 - analysis | Tumor Necrosis Factor-alpha - analysis | NF-E2-Related Factor 2 - analysis | NF-E2-Related Factor 2 - metabolism | Oxidative Stress - drug effects | Liver X Receptors - genetics | Antioxidants | Studies | Oxidative stress | Rodents | Cytotoxicity | Gene expression | Veins & arteries | Apoptosis | Cell adhesion & migration
HUVEC | Inflammation | Allicin | Mitochondrial dysfunction | Nrf2 | Atherosclerosis | CANCER-CELLS | APOPTOSIS | PHYSIOLOGY | RISK-FACTORS | FENOFIBRATE | BLOOD-PRESSURE | GARLIC POWDER | HIGH GLUCOSE | THERAPEUTIC TARGETS | GENERATION | Human Umbilical Vein Endothelial Cells | Inflammation - pathology | Neutrophils - cytology | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Liver X Receptors - antagonists & inhibitors | Humans | Sulfinic Acids - pharmacology | Membrane Potential, Mitochondrial - drug effects | RNA Interference | Lipid Peroxidation - drug effects | Neutrophils - metabolism | Malondialdehyde - metabolism | Lipopolysaccharides - toxicity | Cytochromes c - metabolism | Liver X Receptors - metabolism | Mitochondria - metabolism | Mitochondria - drug effects | Cell Adhesion - drug effects | Interleukin-8 - analysis | Tumor Necrosis Factor-alpha - analysis | NF-E2-Related Factor 2 - analysis | NF-E2-Related Factor 2 - metabolism | Oxidative Stress - drug effects | Liver X Receptors - genetics | Antioxidants | Studies | Oxidative stress | Rodents | Cytotoxicity | Gene expression | Veins & arteries | Apoptosis | Cell adhesion & migration
Journal Article
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, ISSN 1107-3756, 04/2016, Volume 37, Issue 4, pp. 1014 - 1022
Hemorrhagic shock (HS) following trauma or major surgery significantly contributes to mortality. However, the mechanisms through which HS activates the...
MEDICINE, RESEARCH & EXPERIMENTAL | NRF2 ENHANCES SUSCEPTIBILITY | OXIDATIVE STRESS | NEUTROPHIL ACTIVATION | hemorrhagic shock | inflammatory response | ACUTE LUNG INJURY | HEPATIC-INJURY | ischemia/reperfusion | CYTOKINE PRODUCTION | PATHWAY | nuclear factor-erythroid 2 p45 subunit-related factor 2 | MICE | pro-inflammatory cytokine | EXPRESSION | RESUSCITATION | Inflammation - pathology | Leukocytes - pathology | Up-Regulation | Liver - pathology | Shock, Hemorrhagic - complications | Humans | Macrophages, Peritoneal - pathology | Male | NF-E2-Related Factor 2 - immunology | Leukocytes - immunology | Inflammation - complications | Liver - immunology | Female | NF-E2-Related Factor 2 - genetics | Shock, Hemorrhagic - pathology | Lung - pathology | Mice, Inbred C57BL | Macrophages, Peritoneal - immunology | Inflammation - immunology | Mice, Inbred ICR | Mice, Knockout | NF-E2-Related Factor 2 - analysis | Animals | Shock, Hemorrhagic - genetics | Inflammation - genetics | Mice | Mice, Inbred BALB C | Shock, Hemorrhagic - immunology | Macrophages, Peritoneal - metabolism | Lung - immunology
MEDICINE, RESEARCH & EXPERIMENTAL | NRF2 ENHANCES SUSCEPTIBILITY | OXIDATIVE STRESS | NEUTROPHIL ACTIVATION | hemorrhagic shock | inflammatory response | ACUTE LUNG INJURY | HEPATIC-INJURY | ischemia/reperfusion | CYTOKINE PRODUCTION | PATHWAY | nuclear factor-erythroid 2 p45 subunit-related factor 2 | MICE | pro-inflammatory cytokine | EXPRESSION | RESUSCITATION | Inflammation - pathology | Leukocytes - pathology | Up-Regulation | Liver - pathology | Shock, Hemorrhagic - complications | Humans | Macrophages, Peritoneal - pathology | Male | NF-E2-Related Factor 2 - immunology | Leukocytes - immunology | Inflammation - complications | Liver - immunology | Female | NF-E2-Related Factor 2 - genetics | Shock, Hemorrhagic - pathology | Lung - pathology | Mice, Inbred C57BL | Macrophages, Peritoneal - immunology | Inflammation - immunology | Mice, Inbred ICR | Mice, Knockout | NF-E2-Related Factor 2 - analysis | Animals | Shock, Hemorrhagic - genetics | Inflammation - genetics | Mice | Mice, Inbred BALB C | Shock, Hemorrhagic - immunology | Macrophages, Peritoneal - metabolism | Lung - immunology
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0133876
Nuclear factor erythroid-2-related factor 2 (NFE2L2) is a transcription factor associated with resistance to chemotherapy and increased tumor growth. NRF2 is...
METHYLATION | CANCER CELLS | NF-E2-RELATED FACTOR-2 NRF2 | MULTIDISCIPLINARY SCIENCES | CELL-PROLIFERATION | TRANSCRIPTION FACTOR | EXPRESSION | ASSOCIATION | Cervical Intraepithelial Neoplasia - pathology | Cervix Uteri - metabolism | Cell Proliferation | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Uterine Cervical Neoplasms - pathology | Intracellular Signaling Peptides and Proteins - metabolism | Carcinogenesis - metabolism | DNA Methylation | Uterine Cervical Neoplasms - metabolism | Adult | Cervix Uteri - pathology | Female | NF-E2-Related Factor 2 - genetics | Intracellular Signaling Peptides and Proteins - genetics | Kelch-Like ECH-Associated Protein 1 | Carcinogenesis - genetics | Intracellular Signaling Peptides and Proteins - analysis | Uterine Cervical Neoplasms - genetics | Carcinogenesis - pathology | NF-E2-Related Factor 2 - analysis | NF-E2-Related Factor 2 - metabolism | Cell Line, Tumor | CpG Islands | Cervical Intraepithelial Neoplasia - metabolism | Aged | Cervical Intraepithelial Neoplasia - genetics | Cell Movement | Epigenetic inheritance | Squamous cell carcinoma | Care and treatment | Chemotherapy | Development and progression | Research | Health aspects | Risk factors | Cancer | Oxidative stress | Transcription factors | Lung cancer | Metastasis | Drug resistance | Tissues | Carcinogenesis | Lymph nodes | Proteins | Carcinogens | Cell growth | Tumorigenesis | CpG islands | Aggressive behavior | Gynecology | Gene expression | Resistance factors | Pathology | Hospitals | Womens health | Cell lines | Cell migration | Cervical cancer | Tumors | Apoptosis
METHYLATION | CANCER CELLS | NF-E2-RELATED FACTOR-2 NRF2 | MULTIDISCIPLINARY SCIENCES | CELL-PROLIFERATION | TRANSCRIPTION FACTOR | EXPRESSION | ASSOCIATION | Cervical Intraepithelial Neoplasia - pathology | Cervix Uteri - metabolism | Cell Proliferation | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Uterine Cervical Neoplasms - pathology | Intracellular Signaling Peptides and Proteins - metabolism | Carcinogenesis - metabolism | DNA Methylation | Uterine Cervical Neoplasms - metabolism | Adult | Cervix Uteri - pathology | Female | NF-E2-Related Factor 2 - genetics | Intracellular Signaling Peptides and Proteins - genetics | Kelch-Like ECH-Associated Protein 1 | Carcinogenesis - genetics | Intracellular Signaling Peptides and Proteins - analysis | Uterine Cervical Neoplasms - genetics | Carcinogenesis - pathology | NF-E2-Related Factor 2 - analysis | NF-E2-Related Factor 2 - metabolism | Cell Line, Tumor | CpG Islands | Cervical Intraepithelial Neoplasia - metabolism | Aged | Cervical Intraepithelial Neoplasia - genetics | Cell Movement | Epigenetic inheritance | Squamous cell carcinoma | Care and treatment | Chemotherapy | Development and progression | Research | Health aspects | Risk factors | Cancer | Oxidative stress | Transcription factors | Lung cancer | Metastasis | Drug resistance | Tissues | Carcinogenesis | Lymph nodes | Proteins | Carcinogens | Cell growth | Tumorigenesis | CpG islands | Aggressive behavior | Gynecology | Gene expression | Resistance factors | Pathology | Hospitals | Womens health | Cell lines | Cell migration | Cervical cancer | Tumors | Apoptosis
Journal Article
International Journal of Clinical and Experimental Pathology, ISSN 1936-2625, 2014, Volume 7, Issue 3, pp. 1124 - 1131
Due to emergence of resistant tumor populations, prognosis for metastatic colorectal cancer (CRC) patients remains poor and five-year survival rate is still...
Cmyc | NF-E2-related factor 2 (Nrf2) | NAD(P)H quinine oxidoreductase 1 (NQO1) | Colorectal cancer (CRC) | Multidrug resistant protein 1 (MRP1) | P53 | ACTIVATION | multidrug resistant protein 1 (MRP1) | HUMAN LUNG-CANCER | INDUCTION | PATHOLOGY | p53 | GENE | ONCOLOGY | PATHWAY | ANTIOXIDANT | NAD(P) H quinine oxidoreductase 1 (NQO1) | RESISTANCE | cmyc | TRANSCRIPTION FACTOR | ADAPTIVE RESPONSE | EXPRESSION | Colorectal Neoplasms - mortality | Immunohistochemistry | Multidrug Resistance-Associated Proteins - analysis | Prognosis | Tumor Suppressor Protein p53 - biosynthesis | Biomarkers, Tumor - analysis | Humans | Survival Rate | Multidrug Resistance-Associated Proteins - biosynthesis | Tumor Suppressor Protein p53 - analysis | NAD(P)H Dehydrogenase (Quinone) - biosynthesis | NF-E2-Related Factor 2 - analysis | NAD(P)H Dehydrogenase (Quinone) - analysis | NF-E2-Related Factor 2 - biosynthesis | Colorectal Neoplasms - metabolism
Cmyc | NF-E2-related factor 2 (Nrf2) | NAD(P)H quinine oxidoreductase 1 (NQO1) | Colorectal cancer (CRC) | Multidrug resistant protein 1 (MRP1) | P53 | ACTIVATION | multidrug resistant protein 1 (MRP1) | HUMAN LUNG-CANCER | INDUCTION | PATHOLOGY | p53 | GENE | ONCOLOGY | PATHWAY | ANTIOXIDANT | NAD(P) H quinine oxidoreductase 1 (NQO1) | RESISTANCE | cmyc | TRANSCRIPTION FACTOR | ADAPTIVE RESPONSE | EXPRESSION | Colorectal Neoplasms - mortality | Immunohistochemistry | Multidrug Resistance-Associated Proteins - analysis | Prognosis | Tumor Suppressor Protein p53 - biosynthesis | Biomarkers, Tumor - analysis | Humans | Survival Rate | Multidrug Resistance-Associated Proteins - biosynthesis | Tumor Suppressor Protein p53 - analysis | NAD(P)H Dehydrogenase (Quinone) - biosynthesis | NF-E2-Related Factor 2 - analysis | NAD(P)H Dehydrogenase (Quinone) - analysis | NF-E2-Related Factor 2 - biosynthesis | Colorectal Neoplasms - metabolism
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 1900, Volume 137, Issue 19, pp. 6232 - 6244
Despite the known propensity of small-molecule electrophiles to react with numerous cysteine-active proteins, biological actions of individual signal inducers...
OXIDATIVE STRESS | ACTIVATION | LIPID-PEROXIDATION | NRF2 | POTENCY | ANTIOXIDANT | ENZYMES | NF-E2-RELATED FACTOR-2 | TRANSDUCTION | INDUCERS | CHEMISTRY, MULTIDISCIPLINARY | NF-E2-Related Factor 2 - analysis | Oxidation-Reduction | Signal Transduction | Humans | NF-E2-Related Factor 2 - metabolism | HEK293 Cells | Intracellular Signaling Peptides and Proteins - analysis | Models, Molecular | Intracellular Signaling Peptides and Proteins - metabolism | Kelch-Like ECH-Associated Protein 1 | Alkylation | Proteins | Oxidation-reduction reaction | Cellular signal transduction | Chemical properties | Research
OXIDATIVE STRESS | ACTIVATION | LIPID-PEROXIDATION | NRF2 | POTENCY | ANTIOXIDANT | ENZYMES | NF-E2-RELATED FACTOR-2 | TRANSDUCTION | INDUCERS | CHEMISTRY, MULTIDISCIPLINARY | NF-E2-Related Factor 2 - analysis | Oxidation-Reduction | Signal Transduction | Humans | NF-E2-Related Factor 2 - metabolism | HEK293 Cells | Intracellular Signaling Peptides and Proteins - analysis | Models, Molecular | Intracellular Signaling Peptides and Proteins - metabolism | Kelch-Like ECH-Associated Protein 1 | Alkylation | Proteins | Oxidation-reduction reaction | Cellular signal transduction | Chemical properties | Research
Journal Article